Osteonecrosis of the jaw during biyearly treatment with zoledronic acid for aromatase inhibitor associated bone loss in early breast cancer: A literature review

Osteonecrosis of the jaw (ONJ) is one of the most relevant and specific complication of biphosphonates. ONJ in patients receiving zoledronic acid every 3 to 4 weeks is frequently described, but the ONJ biyearly regimen used to reduce aromatase inhibitor associated bone loss (AIBL), is rarely reporte...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Bone Oncol
Hoofdauteurs: Kourie, Hampig Raphael, Antoun, Joelle, El Rassy, Elie, Rassy, Marc, Sader-Ghorra, Claude, Kattan, Joseph
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Elsevier 2015
Onderwerpen:
Review Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4648993/
https://ncbi.nlm.nih.gov/pubmed/26587372
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jbo.2015.09.001
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items